Executive Summary
Samsung and co‑petitioners have filed an IPR petition seeking to invalidate 18 claims of Omni MedSci’s wearable health‑monitoring patent. They argue the claims are obvious over a combination of prior‑art references and that collateral estoppel bars re‑litigation.
Related Cases
Google LLCvs138 East LCD Advancements Limited et al.
The PTAB cancelled original claims 1, 2, and 4-6 but denied cancellation of substitute claims 7-12. The Board found sufficient motivation to combine prior art references (Parulski/Safonov, Parulski/Johnson) for obviousness under 35 U.S.C. § 103(a).
Cala Health, Inc.vsEMKinetics, Inc.
Cala Health and EMKinetics settled their dispute over two patents, filing a joint motion that led the PTAB to terminate the IPRs before any trial was instituted.
Apple Inc.vsMyPort Technologies, Inc.
MyPort’s preliminary response argues that Apple’s IPR petition fails to show a single device capturing both location and time data, violating the particularity requirement. The patent owner seeks denial of institution.
Dropbox, Inc.vsMotion Offense LLC
Dropbox successfully petitioned to invalidate Motion Offense LLC's patent claims based on obviousness over combinations of prior art references like Riepling and Meisels. The PTAB granted the petition, instituting the case for trial.
Phison Electronics CorporationvsVervain, LLC
The PTAB denied Phison’s petition to institute a post‑grant review of Vervain’s NAND‑flash storage patent, finding the challenger failed to show any claim was likely unpatentable.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.